Literature DB >> 16540731

A c-kit-negative gastrointestinal stromal tumor with a platelet-derived growth factor receptor alpha mutation.

Jorge C Isaac1, Carlynn Willmore, Joseph A Holden, Lester J Layfield.   

Abstract

Gastrointestinal stromal tumors (GISTs) are well-recognized mesenchymal neoplasms of the intestinal tract. A diagnosis of GIST is not always possible using IHC techniques for detection of c-kit. The authors describe a 64-year-old man who presented with an upper abdominal quadrant mass. Histology showed a predominantly epithelioid neoplasm with focal "spindle cell" areas. IHC studies were positive for muscle markers and negative for c-kit. The morphologic and immunophenotypic appearance could be compatible with either a smooth muscle tumor or a GIST. Because of the differences in treatment protocols and prognosis between these two entities, molecular studies to detect c-kit or platelet-derived growth factor receptor (PDGFR) activating mutations were performed. No mutations were found in the c-kit gene, but a mutation was detected in the PDGFR gene. This additional molecular study allowed the authors to formulate the precise diagnosis of a c-kit-negative GIST with strong smooth muscle marker expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540731     DOI: 10.1097/01.pai.0000156866.84350.ec

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  2 in total

1.  Clinicopathological and immunohistochemical features of gastointestinal stromal tumors.

Authors:  Yu Na Kang; Hye Ra Jung; Ilseon Hwang
Journal:  Cancer Res Treat       Date:  2010-09-30       Impact factor: 4.679

2.  Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis.

Authors:  Liang Zong; Ping Chen
Journal:  World J Surg Oncol       Date:  2014-03-28       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.